Multiple sclerosis: diagnosis and the management of acute relapses
- PMID: 15879043
- PMCID: PMC1743263
- DOI: 10.1136/pgmj.2004.029413
Multiple sclerosis: diagnosis and the management of acute relapses
Abstract
Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system that may result in a wide range of neurological symptoms and accumulating disability. Its course is unpredictable resulting in a changing pattern of clinical need. Diagnostic criteria for multiple sclerosis require objective evidence for dissemination in space and time. The diagnostic and management process should follow good practice guidelines with the person at the centre of the process. Appropriate support and information should be available from the time of diagnosis. Continuing education is key in enabling the person to actively participate in their management. In the event of an acute relapse the person should have direct access to the most appropriate local service. Provided medical causes have been excluded, corticosteroid treatment to hasten the recovery from the relapse should be considered. Management of an acute relapse should be comprehensive addressing any medical, functional, or psychosocial sequelae.
Similar articles
-
Multiple sclerosis: clinical presentation, diagnosis and treatment.Am Fam Physician. 1996 Sep 15;54(4):1301-6, 1309-11. Am Fam Physician. 1996. PMID: 8816574 Review.
-
Pediatric multiple sclerosis.J Child Neurol. 2012 Nov;27(11):1378-83. doi: 10.1177/0883073812452784. Epub 2012 Aug 21. J Child Neurol. 2012. PMID: 22914372 Review.
-
Acute inflammatory demyelinating optic neuritis: evidence-based visual and neurological considerations.Neurologist. 2008 Jul;14(4):207-23. doi: 10.1097/NRL.0b013e31816f27fe. Neurologist. 2008. PMID: 18617847 Review.
-
Steroid treatment for relapses in multiple sclerosis - the evidence urges shared decision-making.Acta Neurol Scand. 2004 Jul;110(1):1-5. doi: 10.1111/j.1600-0404.2004.00284.x. Acta Neurol Scand. 2004. PMID: 15180800 Review.
-
[Multiple sclerosis in children: clarifying its place among the demyelinating spectrum].Invest Clin. 2006 Dec;47(4):413-25. Invest Clin. 2006. PMID: 17176909 Review. Spanish.
Cited by
-
Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010.BMC Neurol. 2014 Jan 14;14:11. doi: 10.1186/1471-2377-14-11. BMC Neurol. 2014. PMID: 24423119 Free PMC article.
-
Effects of physical comorbidities on disability progression in multiple sclerosis.Neurology. 2018 Jan 30;90(5):e419-e427. doi: 10.1212/WNL.0000000000004885. Epub 2018 Jan 3. Neurology. 2018. PMID: 29298855 Free PMC article.
-
Beta-interferon exposure and onset of secondary progressive multiple sclerosis.Eur J Neurol. 2015 Jun;22(6):990-1000. doi: 10.1111/ene.12698. Epub 2015 Apr 6. Eur J Neurol. 2015. PMID: 25846809 Free PMC article.
-
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.BMC Med Inform Decis Mak. 2012 Jul 18;12:73. doi: 10.1186/1472-6947-12-73. BMC Med Inform Decis Mak. 2012. PMID: 22809360 Free PMC article.
-
Multiple sclerosis following a spinal cord injury: a rare and unfortunate case.Spinal Cord Ser Cases. 2016 Jan 7;2:15027. doi: 10.1038/scsandc.2015.27. eCollection 2016. Spinal Cord Ser Cases. 2016. PMID: 28053730 Free PMC article.